Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Karine Desboeuf »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Karin Wirdefeldt < Karine Desboeuf < Karine Mention  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000457 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
000463 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
000508 (2001) Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Human
2Humans
2Parkinson disease
2Parkinson's disease
2Prospective Studies
1Aged
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (therapeutic use)
1Antiparkinson agent
1Balneology (economics)
1Balneology (methods)
1Bromocriptine
1Bromocriptine (administration & dosage)
1Bromocriptine (therapeutic use)
1Chemotherapy
1Clinical trial
1Cost-Benefit Analysis
1Cross-Over Studies
1Drug Therapy, Combination
1Economic analysis
1Ergot derivatives
1Female
1Follow-Up Studies
1France (epidemiology)
1Health Care Costs
1Health Resorts
1Levodopa
1Levodopa (administration & dosage)
1Levodopa (therapeutic use)
1Long term
1Male
1Massage (economics)
1Middle Aged
1Mortality
1Mortality (trends)
1Parkinson Disease (diagnosis)
1Parkinson Disease (drug therapy)
1Parkinson Disease (economics)
1Parkinson Disease (mortality)
1Parkinson Disease (therapy)
1Pilot Projects
1Quality of Life
1Quality of life
1Questionnaires
1Severity of Illness Index
1Thermal cure
1Time Factors
1Treatment
1Treatment Outcome
1Treatment efficiency
1bromocriptine
1clinical trial
1cost effectiveness
1levodopa
1mortality
1quality of life
1spa therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Karine Desboeuf" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Karine Desboeuf" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Karine Desboeuf
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024